The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Dashboard: Filter Bricks
Main page content
Displaying results 1 - 3 of 3
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep21-02-01-003.png?itok=Gn_osjAz)
Publication ID: PEP21-02-01-003
Published:
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep21-02-01-002.png?itok=XUnpe8kE)
Publication ID: PEP21-02-01-002
Published:
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
![Faces of Change: Do I Have a Problem With Alcohol or Drugs?](/sites/default/files/styles/product_thumbnail_dashboard/public/sma15-4174.jpg?itok=0QcdxI_7)
Publication ID: SMA15-4174
Published:
This resource explores the lives of five characters living with different substance use disorder conditions. It illustrates the stages of change and the value of treatment, recovery, and motivational incentives. It also includes a change plan worksheet.